Marshall Wace, LLP Bausch & Lomb Corp Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 374,467 shares of BLCO stock, worth $6.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
374,467
Previous 463,622
19.23%
Holding current value
$6.28 Million
Previous $8.94 Million
24.18%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BLCO
# of Institutions
124Shares Held
37.8MCall Options Held
118KPut Options Held
299K-
Maple Rock Capital Partners Inc. Toronto, A63.62MShares$60.7 Million2.04% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$58.7 Million0.69% of portfolio
-
Goldentree Asset Management LP New York, NY3.36MShares$56.3 Million5.89% of portfolio
-
Alberta Investment Management Corp Edmonton, A03.01MShares$50.4 Million0.41% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.91MShares$32.1 Million0.03% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $5.87B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...